| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |